Public Laboratory Companies Eye More Lab Outreach Acquisitions

PUBLICLY-TRADED CLINICAL LABORATORY COMPANIES released second quarter 2022 financial reports that confirmed a softening demand for COVID-19 tests, even as their base business revenues grew compared to last year. While continuing to address ongoing needs for SARS-CoV-2 testing, company leaders said during earnings calls that they are prioritizing the following business areas: Acquiring hospital laboratories. …

Public Laboratory Companies Eye More Lab Outreach Acquisitions Read More »

To access this post, you must purchase The Dark Report.

Public Laboratory Companies Eye More Lab Outreach Acquisitions

Companies want to get back to base business as COVID-19 test volumes fall, according to earnings reports

Comments

TABLE OF CONTENTS

Need A Group Membership? Company Discounts are Available!

You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

You have read 0 of 1 of your complimentary articles this month